EuropaBio participates at the BIO International Convention 2022 in San Diego
Brussels, 7 June 2022 – On June 13-16 EuropaBio will lead European legislative discussions within the programme of the BIO International Convention 2022 in San Diego, California which is back in person for the first time in two years. The Convention features 100+ interactive sessions across 4 days, covering a variety of therapeutic areas, business development, digital health, patient advocacy, public policy, next-generation biotherapeutics, and the latest updates from industry experts on COVID-19 and the vaccine.
‘’We are very excited to be back in person at BIO Convention in San Diego this year and meet our members and partners from the U.S. This is the most important global business event in healthcare biotechnology and we are proud to represent Europe’s advancing science, business and policy together with members, through the programme and EuropaBio hosted networking events. We will enjoy every moment of the global community being back together”, said Dr Claire Skentelbery, Director General of EuropaBio.
On June 12, EuropaBio’s Director General Dr Claire Skentelbery will participate in the International Council of Biotechnology Associations (ICBA) Annual Meeting. The ICBA is a coalition of non-profit, national biotechnology trade associations which is the global voice of the industry in international for a, with the goal of promoting continued innovation in the human health, agriculture, and industrial and environmental sectors. Dr Skentelbery has been nominated for the Vice Chair position of ICBA in 2022 with the elections taking place on the day of the meeting.
On June 13 (18.20-20:00 PDT), EuropaBio together with the European Innovation Council, Estonian Business and Innovation Agency, the Italian Trade Agency and the Switzerland Global Enterprise, hosts an invite-only evening reception celebrating the biotechnology strength of Europe in the world.
On June 15 (11:00 AM-12:00 PM PDT) EuropaBio will lead a panel discussion ‘’The big bang in pharma legislation: A European epicentre shaping global healthcare and competitive industry’’ at BIO and invites all delegates to join us to discuss the future of healthcare innovation as impacted by European changes.
• The drive for reform – the world is changing and with it must change the pathway for medicines so that all patients benefit;
• What do SMEs, mid-sized and multi-national companies need from legislation to ensure they can deliver innovation in the long term?
• When change is inevitable, how does industry roll up its shelves and help collectively drive a new future, rather than waiting for it to be imposed?
• How will European reform impact the global biopharma sector in a time of geopolitical realignment and regrowth?
More information, the list of speakers and registration arehere.
Are you interested in meeting EuropaBio representatives at BIO International Convention in San Diego? Please get in touch with Dr Claire Skentelbery, Director General, EuropaBio; Dovile Sandaraite, Communications Manager, EuropaBio.